Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.
D000200:Action Potentials / Q000187:drug effects*; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001572:Benzofurans / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003318:Corneal Opacity / Q000139:chemically induced; D004048:Diethylamines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006325:Heart Atria / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007463:Iodobenzoates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008875:Middle Aged; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D001572:Benzofurans; D004048:Diethylamines; D007463:Iodobenzoates